长链非编码RNA介导的ceRNA网络在膀胱癌中的作用
The Role of Long Chain Non Coding RNA Mediated ceRNA Network in Bladder Cancer
DOI: 10.12677/acm.2025.152485, PDF,   
作者: 赵红丽, 李晓霞*：牡丹江医科大学公共卫生学院，黑龙江 牡丹江；丁佳君：牡丹江医科大学基础医学院，黑龙江 牡丹江
关键词: 膀胱癌；长链非编码RNA；竞争性内源RNA；Bladder Cancer； Long Non-Coding RNA； ceRNA
摘要: 膀胱癌(Bladder Cancer, BC)位列全球最常见的十种癌症之中，其患病率与致死率均处于较高水平。长链非编码核糖核酸(lncRNAs, 即Long non-coding RNAs)指的是那些核苷酸数量在200至100,000个之间的核糖核酸分子，这类分子几乎不编码蛋白质或仅有极低的编码潜力，并且近年来已经成为了研究热点。近年来，lncRNA逐渐被发现参与到多种生理病理过程之中，并与多种疾病的发生发展有关，其中尤其以癌症为甚。在膀胱癌中，lncRNA同样起到了关键的作用。它既可作为肿瘤抑制基因，也可能成为肿瘤促进基因。有充分证据表明，lncRNA能作为竞争性内源RNA (Competing endogenous RNA, ceRNA)与微小RNA (microRNA, miRNA)结合，进而调控靶基因的表达。这已被认为在许多类型的肿瘤中发挥着不可或缺的作用。本文就lncRNA在膀胱癌中的ceRNA机制作一综述。
Abstract: Bladder cancer (BC) ranks among the top ten most prevalent cancers globally, characterized by high incidence and mortality rates. Long noncoding RNAs (lncRNAs) are a class of RNA molecules with transcript lengths ranging from 200 to 100,000 nucleotides; they either lack or have minimal protein-coding capacity. In recent years, lncRNAs have garnered significant attention due to their involvement in various physiological and pathological processes, and they are increasingly recognized as being closely associated with the pathogenesis of numerous diseases, particularly in oncology. Within the context of bladder cancer, lncRNAs play a pivotal role, functioning both as tumor suppressors and oncogenes. Mounting evidence suggests that lncRNAs can act as competitive endogenous RNAs (ceRNAs) by binding to microRNAs (miRNAs), thereby influencing and modulating the expression of target genes, a role considered essential in multiple types of tumors. This review examines the role of the lncRNA ceRNA mechanism in bladder cancer.
文章引用：赵红丽, 丁佳君, 李晓霞. 长链非编码RNA介导的ceRNA网络在膀胱癌中的作用[J]. 临床医学进展, 2025, 15(2): 1369-1376. https://doi.org/10.12677/acm.2025.152485

参考文献

[1] Matuszczak, M., Kiljańczyk, A. and Salagierski, M. (2022) A Liquid Biopsy in Bladder Cancer—The Current Landscape in Urinary Biomarkers. International Journal of Molecular Sciences, 23, Article 8597. [Google Scholar] [CrossRef] [PubMed]
[2] Lobo, N., Afferi, L., Moschini, M., Mostafid, H., Porten, S., Psutka, S.P., et al. (2022) Epidemiology, Screening, and Prevention of Bladder Cancer. European Urology Oncology, 5, 628-639. [Google Scholar] [CrossRef] [PubMed]
[3] 姜庆, 徐苓傈, 杨洋. 早期膀胱癌的手术治疗进展研究[J]. 中国临床医生杂志, 2024, 52(6): 642-644.
[4] Phé, V. (2022) Bladder Cancer in Neurogenic Patients. World Journal of Urology, 40, 1895-1896. [Google Scholar] [CrossRef] [PubMed]
[5] Babjuk, M., Böhle, A., Burger, M., Capoun, O., Cohen, D., Compérat, E.M., et al. (2017) EAU Guidelines on Non–muscle-Invasive Urothelial Carcinoma of the Bladder: Update 2016. European Urology, 71, 447-461. [Google Scholar] [CrossRef] [PubMed]
[6] Zhao, X., Lan, Y. and Chen, D. (2022) Exploring Long Non-Coding RNA Networks from Single Cell Omics Data. Computational and Structural Biotechnology Journal, 20, 4381-4389. [Google Scholar] [CrossRef] [PubMed]
[7] Choi, S., Kim, H. and Nam, J. (2019) The Small Peptide World in Long Noncoding RNAs. Briefings in Bioinformatics, 20, 1853-1864. [Google Scholar] [CrossRef] [PubMed]
[8] 牛春阳, 薛琳琳, 计红, 等. lncRNA生物学功能研究进展[J]. 中国生物制品学杂志, 2019, 32(2): 228-232+237.
[9] Hanahan, D. and Weinberg, R.A. (2011) Hallmarks of Cancer: The Next Generation. Cell, 144, 646-674. [Google Scholar] [CrossRef] [PubMed]
[10] Choudhari, R., Sedano, M.J., Harrison, A.L., Subramani, R., Lin, K.Y., Ramos, E.I., et al. (2020) Long Noncoding RNAs in Cancer: From Discovery to Therapeutic Targets. In: Advances in Clinical Chemistry, Elsevier, 105-147. [Google Scholar] [CrossRef] [PubMed]
[11] Wu, X., Sui, Z., Zhang, H., Wang, Y. and Yu, Z. (2020) Integrated Analysis of LncRNA-Mediated Cerna Network in Lung Adenocarcinoma. Frontiers in Oncology, 10, Article 554749. [Google Scholar] [CrossRef] [PubMed]
[12] Liu, Z., Wang, W., Jiang, J., Bao, E., Xu, D., Zeng, Y., et al. (2013) Downregulation of GAS5 Promotes Bladder Cancer Cell Proliferation, Partly by Regulating CDK6. PLOS ONE, 8, e73991. [Google Scholar] [CrossRef] [PubMed]
[13] Wang, M., Guo, C., Wang, L., Luo, G., Huang, C., Li, Y., et al. (2018) Long Noncoding RNA GAS5 Promotes Bladder Cancer Cells Apoptosis through Inhibiting EZH2 Transcription. Cell Death & Disease, 9, Article No. 238. [Google Scholar] [CrossRef] [PubMed]
[14] Su, H., Tao, T., Yang, Z., Kang, X., Zhang, X., Kang, D., et al. (2019) Circular RNA cTFRC Acts as the Sponge of MicroRNA-107 to Promote Bladder Carcinoma Progression. Molecular Cancer, 18, Article No. 27. [Google Scholar] [CrossRef] [PubMed]
[15] 刘泓键, 奉友刚, 余周, 等. 沉默长链非编码RNA HOTAIR对膀胱癌细胞增殖、凋亡的影响及其机制[J]. 山东医药, 2018, 58(48): 37-40.
[16] Shang, C., Guo, Y., Zhang, H. and Xue, Y. (2016) Long Noncoding RNA HOTAIR Is a Prognostic Biomarker and Inhibits Chemosensitivity to Doxorubicin in Bladder Transitional Cell Carcinoma. Cancer Chemotherapy and Pharmacology, 77, 507-513. [Google Scholar] [CrossRef] [PubMed]
[17] Gao, L., Zhao, Y., Ma, X. and Zhang, L. (2021) Integrated Analysis of LncRNA-miRNA-mRNA Cerna Network and the Potential Prognosis Indicators in Sarcomas. BMC Medical Genomics, 14, Article No. 67. [Google Scholar] [CrossRef] [PubMed]
[18] Xu, J., Xu, J., Liu, X. and Jiang, J. (2022) The Role of LncRNA-Mediated Cerna Regulatory Networks in Pancreatic Cancer. Cell Death Discovery, 8, Article No. 287. [Google Scholar] [CrossRef] [PubMed]
[19] 赵丽, 马慧, 孙艳. 竞争性内源性RNA在神经退行性疾病中作用的研究进展[J]. 癌变 畸变 突变, 2020, 32(3): 238-240.
[20] 郑继青, 刘云, 龙耀斌, 等. lncRNA介导ceRNA调控网络作用于缺血性脑卒中的研究进展[J]. 中华神经医学杂志, 2021, 20(11): 1160-1166.
[21] Shahpari, M., Hashemi, M., Younesirad, T., Hasanzadeh, A., Mosanne, M.M. and Ahmadifard, M. (2024) The Functional Roles of Competitive Endogenous RNA (ceRNA) Networks in Apoptosis in Human Cancers: The circRNA/miRNA/mRNA Regulatory Axis and Cell Signaling Pathways. Heliyon, 10, e37089. [Google Scholar] [CrossRef] [PubMed]
[22] 陈欣欣, 陈晓隆. 长链非编码RNA与微RNA相互作用在血管生成中的研究进展[J]. 中国医科大学学报, 2023, 52(5): 457-460.
[23] 钱镭元, 修光辉, 孙洁, 等. lncRNA-miRNA-mRNA轴在脓毒症炎症免疫机制中的研究进展[J]. 华中科技大学学报(医学版), 2023, 52(1): 117-122.
[24] Quan, J., Dong, D., Lun, Y., Sun, B., Sun, H., Wang, Q., et al. (2020) Circular RNA Circhiat1 Inhibits Proliferation and Epithelial-Mesenchymal Transition of Gastric Cancer Cell Lines through Downregulation of miR-21. Journal of Biochemical and Molecular Toxicology, 34, e22458. [Google Scholar] [CrossRef] [PubMed]
[25] Zeng, X., Xiao, J., Bai, X., Liu, Y., Zhang, M., Liu, J., et al. (2022) Research Progress on the circRNA/lncRNA-miRNA-mRNA Axis in Gastric Cancer. Pathology—Research and Practice, 238, Article 154030. [Google Scholar] [CrossRef] [PubMed]
[26] Liu, B., Wu, S., Ma, J., Yan, S., Xiao, Z., Wan, L., et al. (2018) LncRNA GAS5 Reverses EMT and Tumor Stem Cell-Mediated Gemcitabine Resistance and Metastasis by Targeting miR-221/SOCS3 in Pancreatic Cancer. Molecular Therapy—Nucleic Acids, 13, 472-482. [Google Scholar] [CrossRef] [PubMed]
[27] Zhang, L., Li, Y., Fu, C., Yang, L., Li, G., Wu, Y., et al. (2024) Exploration and Validation of Cerna Regulatory Networks in Colorectal Cancer Based on Associations Whole Transcriptome Sequencing. Scientific Reports, 14, Article No. 20446. [Google Scholar] [CrossRef] [PubMed]
[28] Luo, Y., Li, H., Huang, H., Xue, L., Li, H., Liu, L., et al. (2021) Integrated Analysis of Cerna Network in Hepatocellular Carcinoma Using Bioinformatics Analysis. Medicine, 100, e26194. [Google Scholar] [CrossRef] [PubMed]
[29] Zhou, Y., Zhan, Y., Jiang, W., Liu, H. and Wei, S. (2022) Long Noncoding RNAs and Circular RNAs in the Metabolic Reprogramming of Lung Cancer: Functions, Mechanisms, and Clinical Potential. Oxidative Medicine and Cellular Longevity, 2022, 1-17. [Google Scholar] [CrossRef] [PubMed]
[30] Li, H., Gong, X., Li, Z., Qin, W., He, C., Xing, L., et al. (2021) Role of Long Non-Coding RNAs on Bladder Cancer. Frontiers in Cell and Developmental Biology, 9, Article 672679. [Google Scholar] [CrossRef] [PubMed]
[31] Takai, D. (2001) Large Scale Mapping of Methylcytosines in CTCF-Binding Sites in the Human H19 Promoter and Aberrant Hypomethylation in Human Bladder Cancer. Human Molecular Genetics, 10, 2619-2626. [Google Scholar] [CrossRef] [PubMed]
[32] Lv, M., Zhong, Z., Huang, M., Tian, Q., Jiang, R. and Chen, J. (2017) LncRNA H19 Regulates Epithelial-Mesenchymal Transition and Metastasis of Bladder Cancer by miR-29b-3p as Competing Endogenous RNA. Biochimica et Biophysica Acta—Molecular Cell Research, 1864, 1887-1899. [Google Scholar] [CrossRef] [PubMed]
[33] Yang, A., Liu, X., Liu, P., Feng, Y., Liu, H., Gao, S., et al. (2021) LncRNA UCA1 Promotes Development of Gastric Cancer via the miR-145/MYO6 Axis. Cellular & Molecular Biology Letters, 26, Article No. 33. [Google Scholar] [CrossRef] [PubMed]
[34] Wu, J., Li, W., Ning, J., Yu, W., Rao, T. and Cheng, F. (2019) Long Noncoding RNA UCA1 Targets miR-582-5p and Contributes to the Progression and Drug Resistance of Bladder Cancer Cells through ATG7-Mediated Autophagy Inhibition. OncoTargets and Therapy, 12, 495-508. [Google Scholar] [CrossRef] [PubMed]
[35] Luo, J., Chen, J., Li, H., Yang, Y., Yun, H., Yang, S., et al. (2017) LncRNA UCA1 Promotes the Invasion and EMT of Bladder Cancer Cells by Regulating the miR‑143/HMGB1 Pathway. Oncology Letters, 14, 5556-5562. [Google Scholar] [CrossRef] [PubMed]
[36] Pan, J., Li, X., Wu, W., Xue, M., Hou, H., Zhai, W., et al. (2016) Long Non-Coding RNA UCA1 Promotes Cisplatin/Gemcitabine Resistance through CREB Modulating miR-196a-5p in Bladder Cancer Cells. Cancer Letters, 382, 64-76. [Google Scholar] [CrossRef] [PubMed]
[37] Xue, M., Li, X., Li, Z. and Chen, W. (2014) Urothelial Carcinoma Associated 1 Is a Hypoxia-Inducible Factor-1α-Targeted Long Noncoding RNA That Enhances Hypoxic Bladder Cancer Cell Proliferation, Migration, and Invasion. Tumor Biology, 35, 6901-6912. [Google Scholar] [CrossRef] [PubMed]
[38] Li, H., Sun, X., Li, Z., Yin, Q., Pang, H., Pan, J., et al. (2017) LncRNA UCA1 Promotes Mitochondrial Function of Bladder Cancer via the miR-195/ARL2 Signaling Pathway. Cellular Physiology and Biochemistry, 43, 2548-2561. [Google Scholar] [CrossRef] [PubMed]
[39] Yuan, J., Gu, L., Chen, L., Yin, Y. and Fan, B. (2021) Annexin A8 Regulated by LncRNA-TUG1/miR-140-3p Axis Promotes Bladder Cancer Progression and Metastasis. Molecular Therapy—Oncolytics, 22, 36-51. [Google Scholar] [CrossRef] [PubMed]
[40] Tan, J., Liu, B., Zhou, L., Gao, J., Wang, X., Liu, Y., et al. (2022) LncRNA TUG1 Promotes Bladder Cancer Malignant Behaviors by Regulating the miR-320a/FOXQ1 Axis. Cellular Signalling, 91, Article 110216. [Google Scholar] [CrossRef] [PubMed]
[41] Yu, G., Zhou, H., Xu, K., et al. (2020) miR-29c-3p Targeting TUG1 Affects Migration and Invasion of Bladder Cancer Cells by Regulating CAPN7 Expression. Journal of Southern Medical University, 40, 1325-1331.
[42] Zhang, Z., Liu, T., Cheng, C., Wang, J., Wang, C., Huang, H., et al. (2022) LncRNA GAS5 Regulates the Wnt/β-Catenin Pathway through the miR-18a-5p/AXIN2/GSK3β Axis to Inhibit the Proliferation and Migration of Bladder Cancer Cells. Carcinogenesis, 43, 1176-1189. [Google Scholar] [CrossRef] [PubMed]
[43] Chen, D., Guo, Y., Chen, Y., Guo, Q., Chen, J., Li, Y., et al. (2020) LncRNA Growth Arrest-Specific Transcript 5 Targets miR-21 Gene and Regulates Bladder Cancer Cell Proliferation and Apoptosis through PTEN. Cancer Medicine, 9, 2846-2858. [Google Scholar] [CrossRef] [PubMed]
[44] Cao, Q., Wang, N., Qi, J., Gu, Z. and Shen, H. (2015) Long Non-Coding RNA-GAS5 Acts as a Tumor Suppressor in Bladder Transitional Cell Carcinoma via Regulation of Chemokine (C-C Motif) Ligand 1 Expression. Molecular Medicine Reports, 13, 27-34. [Google Scholar] [CrossRef] [PubMed]
[45] Shan, G., Tang, T., Xia, Y. and Qian, H. (2019) MEG3 Interacted with miR-494 to Repress Bladder Cancer Progression through Targeting PTEN. Journal of Cellular Physiology, 235, 1120-1128. [Google Scholar] [CrossRef] [PubMed]
[46] Hong, Y., Li, Z., Su, Y., Pu, H. and Zhang, X. (2024) The Cerna Mechanism of LncRNA MEG3/miR-21-5p/SPRY2 in Cell Proliferation and Apoptosis in Bladder Cancer. Critical Reviews in Eukaryotic Gene Expression, 34, 55-68. [Google Scholar] [CrossRef] [PubMed]

为你推荐